Semax is a synthetic heptapeptide analog of the adrenocorticotropic hormone (ACTH) fragment 4–10, with a Pro-Gly-Pro C-terminal modification to improve enzymatic stability. It has been studied for its neurotrophic and neuroprotective properties in preclinical models. Published research has investigated its effects on brain-derived neurotrophic factor (BDNF) expression, cerebral blood flow regulation, oxidative stress modulation, and dopaminergic and serotonergic system interactions. Semax does not exhibit the corticotropic activity associated with full-length ACTH. This lyophilized preparation is intended strictly for in vitro research and laboratory investigation. Not for human consumption.
